PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer
Background. PLOD2 is overexpressed in diverse tumors and plays a vital role in tumorigenesis. However, the prognostic value of PLOD2 in cervical cancer (CESC) remains unclear. Methods. PLOD2 expression and CESC patients’ survival data were collected from the Oncomine, GEPIA, UALCAN, and Kaplan-Meier...
Main Authors: | Guang Li, Xuefeng Wang, Guobing Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2021/5512340 |
Similar Items
-
PLOD3 Is Associated with Immune Cell Infiltration and Genomic Instability in Colon Adenocarcinoma
by: Xianyu Deng, et al.
Published: (2021-01-01) -
PCOLCE Is Potent Prognostic Biomarker and Associates With Immune Infiltration in Gastric Cancer
by: Aizhai Xiang, et al.
Published: (2020-12-01) -
Expression and Prognostic Role of PLOD1 in Malignant Glioma
by: Wang H, et al.
Published: (2020-12-01) -
Aberrantly expressed PLOD1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic target
by: Yasutaka Yamada, et al.
Published: (2019-09-01) -
The prognostic landscape of tumor-infiltrating immune cells in cervical cancer
by: Jingnan Wang, et al.
Published: (2019-12-01)